PreveCeutical Medical Inc. (CSE:PREV)

Market Cap	11.96M
Revenue (ttm)	n/a
Net Income (ttm)	-3.12M
Shares Out	598.19M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,965
Average Volume	277,306
Open	0.0200
Previous Close	0.0200
Day's Range	0.0200 - 0.0200
52-Week Range	0.0150 - 0.0600
Beta	0.17
RSI	46.06
Earnings Date	Apr 24, 2026

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating ...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Stephen Van Deventer
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: PREV